IL-17E promoted keratinocyte proliferation and the production of inflammatory cytokines and chemokines by activating the STAT3 transcription factor.182 The findings show that IL-17E mediates a keratinocyte autoregulatory circuit triggered by IL-17 signaling, which may be targeted when treating patients with psoriasis.182. Here, IL25 is linked to psoriasis.